| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 02/25/1999 | WO1999008648A2 Hair conditioner and 2-in-1 conditioning shampoo |
| 02/25/1999 | WO1999008500A2 New crystalline form of omeprazole |
| 02/25/1999 | WO1998046243A3 Pharmaceutical compositions having appetite suppressant activity |
| 02/25/1999 | CA2363810A1 New form of omeprazole |
| 02/25/1999 | CA2301297A1 2-{3-[4-(2-t-butyl-6- trifluoromethylpyridin-4-yl) piperazin-1-yl] propylmercapto} pyrimidin-4-ol-fumarate |
| 02/25/1999 | CA2300143A1 Hair conditioner and 2-in-1 conditioning shampoo |
| 02/25/1999 | CA2300125A1 Use of ascorbic acid in permanent waving and hair coloring compositions |
| 02/24/1999 | EP0897302A2 Harpagoside-enriched extract from harpagophytum procumbens and processes for producing same |
| 02/24/1999 | CN1209139A Prodrugs of thrombin inhibitors |
| 02/24/1999 | CN1208604A Composition for use in oral cavity |
| 02/24/1999 | CN1042198C Multile emulsions |
| 02/23/1999 | US5874447 High purity organosulfonate salt of paroxetine with excellent stability, solubility; react with a base to make high purity paroxetine, or with a reagent to make the high purity salt of said reagent (ex: paroxetine maleate from maleic acid) |
| 02/23/1999 | CA2123992C Composition containing body activated fragrance for contacting the skin and method of use |
| 02/23/1999 | CA1340402C Quinoline derivatives and processes for preparation thereof |
| 02/18/1999 | WO1999007396A1 Composition comprising propolis and at least an essential oil |
| 02/18/1999 | WO1999007386A1 Composition and method of treating cancer with tannic acid and tannin complexes |
| 02/18/1999 | WO1999007335A1 Effervescent two component dentifrice |
| 02/18/1999 | DE19735410A1 New stable fumarate salt of pyrimidinol derivative dopamine D3 receptor ligand, having improved solubility and suitable for oral administration |
| 02/18/1999 | CA2301068A1 Composition comprising propolis and at least an essential oil |
| 02/18/1999 | CA2300423A1 Effervescent two component dentifrice |
| 02/18/1999 | CA2299322A1 Composition and method of treating cancer with tannic acid and tannin complexes |
| 02/17/1999 | CN1208403A Compounds |
| 02/17/1999 | CN1207902A Antilipemic monascus and its preparation |
| 02/17/1999 | CN1042133C N-substituted azabicycloheptane derivatives, the preparation and use thereof |
| 02/16/1999 | US5872108 Protecting brain tissue from cerebral infarction subsequent to ischemia |
| 02/16/1999 | US5871749 Therapeutic treatment of H. pylori associated gastroduodenal disease |
| 02/11/1999 | WO1999006057A1 Soya extract, process for its preparation and pharmaceutical composition |
| 02/11/1999 | WO1999006044A1 Pharmaceutical composition for acidic lipophilic compounds in a form of a self-emulsifying formulation |
| 02/10/1999 | EP0895478A1 Component b as cicatrizant |
| 02/10/1999 | EP0862446A4 Herbal-based oral composition and process for producing the same |
| 02/10/1999 | CN1207670A Cosmetic composition and method for reducing ageing processes of skin |
| 02/09/1999 | US5869669 Reacting with an oxidizing agent in the presence of a weak acid |
| 02/09/1999 | CA2226091C Cyclosporin-containing soft capsule preparations |
| 02/04/1999 | WO1999005121A1 Derivatives of acyl-piperazinil-pyrimidins, preparation thereof and application as medicaments |
| 02/04/1999 | WO1999005105A1 Thermodynamically stable modification of 1-(4-carbazolyloxy)-3-[2-(2-methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it |
| 02/04/1999 | WO1999005090A1 Aminoethylphenoxyacetic acid derivatives and drugs for pain remission and calculi removal promotion in urinary lithiasis |
| 02/04/1999 | WO1999004780A1 Therapeutic or prophylactic agent for glomerulopathy |
| 02/04/1999 | WO1999004773A2 Method for inhibiting bone resorption |
| 02/04/1999 | WO1999004770A2 A pharmaceutical composition active in reducing production of mcp-1 protein |
| 02/04/1999 | WO1999004765A2 Pharmaceutical compositions containing an effervescent acid-base couple |
| 02/04/1999 | WO1999004756A1 Benefit agent compositions comprising mixtures of alpha-hydroxy esters |
| 02/03/1999 | CN1207100A Novel indole-2,3-done-3-oxime derivatives |
| 02/03/1999 | CN1207044A Cyclosporin-containing soft capsule preparations |
| 02/02/1999 | US5866556 Pyridinylbisphosphonates for use as a therapeutical agent |
| 02/02/1999 | US5866166 Blend of microcrystalline cellulose and compressibility adjuvant |
| 02/02/1999 | US5866159 Pharmaceutical compositions comprising cyclosporins |
| 02/02/1999 | US5866152 Containing pyriproxyfen |
| 02/02/1999 | US5866105 Therapy for onychomycosis; topical applying nail varnish |
| 01/28/1999 | WO1999003859A1 Novel spiroazabicyclic heterocyclic compounds |
| 01/28/1999 | WO1999003504A1 Medicinal compositions for treating immunodeficiency diseases |
| 01/28/1999 | WO1999003479A1 Lipid-based immune modulator composition |
| 01/28/1999 | WO1998049138A3 Vitamin d3 analogs with bis c-20 side chains |
| 01/28/1999 | CA2296503A1 Medicinal compositions for treating immunodeficiency diseases |
| 01/28/1999 | CA2295690A1 Lipid-based immune modulator composition |
| 01/27/1999 | EP0893440A1 Thermodynamically stable modification of 1-(4-carbazolyloxy)-3-[2-(2-methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it |
| 01/27/1999 | EP0735858B1 Skin cleaning composition |
| 01/27/1999 | CN1206348A Extracts of shark cartilage |
| 01/26/1999 | US5864048 Rhein derivatives and new processes for producing rhein derivatives |
| 01/26/1999 | US5863935 Synthesis of indole derivatives of heterocyclic compounds for treatment of headaches and migraines |
| 01/26/1999 | US5863544 Consists of hydroxy acid, polysiloxane and polyol alkyl ester; useful for therapeutical treatment of acne, mycosis, seborrhoeic dermatitis, eczema, rosacea, cutaneous aging or scalp or nail maladies |
| 01/26/1999 | US5863525 Cosmetic formulation |
| 01/26/1999 | US5863520 Images for medical diagnosis of organs |
| 01/26/1999 | CA2069747C Cosmetic technology |
| 01/26/1999 | CA1340329C Superoxide dismutasee |
| 01/23/1999 | CA2243394A1 Methods and compositions for fine lines and/or wrinkles |
| 01/21/1999 | WO1999002496A1 (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders |
| 01/21/1999 | CA2292480A1 (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders |
| 01/20/1999 | EP0891362A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| 01/20/1999 | CN1205700A Indolenlkyl derivatives of benzodioxanmethylamine as 5-HT1A receptor ligands |
| 01/19/1999 | US5861510 Antiarthritic agents, antiulcer agents, restenosis, oral diseases |
| 01/19/1999 | US5861414 Inhibiting blood platelet aggregation for antithrombotic disorders |
| 01/19/1999 | US5861391 Use of dehydroepiandrosterone to treat primary adrenal insufficiency and Addison's disease |
| 01/19/1999 | US5861387 Treatment and prevention of breast and endometrial cancer, bone loss, and for treating endometriosis |
| 01/19/1999 | CA2140874C Oral compositions |
| 01/19/1999 | CA2061607C 1-biphenylimidazole derivatives, their preparation and their therapeutic use |
| 01/14/1999 | WO1999001458A1 Crystalline macrolides and process for their preparation |
| 01/14/1999 | WO1999001428A1 Hydrazine derivatives |
| 01/14/1999 | WO1999001135A1 Pharmaceutical compositions containing eletriptan hemisulphate and caffeine |
| 01/14/1999 | WO1999001121A1 Sertraline salts and sustained-release dosage forms of sertraline |
| 01/14/1999 | CA2295062A1 Hydrazine derivatives |
| 01/13/1999 | EP0889729A1 Linseed drug |
| 01/13/1999 | EP0889725A1 Method for treating bipolar disorder |
| 01/13/1999 | EP0889720A1 Low residue antiperspirant stick composition |
| 01/12/1999 | US5859021 Antiviral combinations |
| 01/12/1999 | US5858983 Inhibiting binding of cell bearing selectin protein to molecule or cell bearing sialyl-lewis x determinant by contacting with antibody bearing said determinant |
| 01/12/1999 | US5858968 Autoimmune model: insulin not used for its endocrinologic effect (does not affect blood sugar levels), but to damp down the host's autoimmune response and prevent autoimmune destruction of pancreatic beta cells, allowing oral dosing |
| 01/12/1999 | US5858684 Contacting recombinant cell with test compound which is not verapamil or gallopamil, determining ability of compound to affect activities of inorganic ion receptor; determination of agonist and antagonist drugs |
| 01/12/1999 | US5858412 Forming aqueous slurry of microcrystalline cellulose and compressibility augmenting agent, drying to form agglomerated particles, adding active agent, incorporating sustained-release carrier |
| 01/12/1999 | US5858344 Oral administration form having acid active substances and a process for its production |
| 01/12/1999 | CA2066785C Glycosaminoglycans in the treatment of diabetic nephropathy and diabetic neuropathy |
| 01/07/1999 | WO1999000380A1 Omeprazole sodium salt |
| 01/07/1999 | WO1999000372A1 Sulfonamide compounds and medicinal use thereof |
| 01/07/1999 | WO1998042321A3 Liquid compositions comprising lamivudine |
| 01/07/1999 | EP0888138A1 Topical formulations for the treatment of nail psoriasis |
| 01/07/1999 | EP0888119A1 Pharmaceutical compositions and methods for the manufacture thereof |
| 01/07/1999 | DE19829229A1 Hydrazinderivate Hydrazine |
| 01/07/1999 | CA2295239A1 Sulfonamide compounds and medicinal use thereof |
| 01/07/1999 | CA2217902A1 Use of gammahydroxybutyrric acid for the treatment of demential syndromes |
| 01/06/1999 | CN1204327A Pharmaceutically active quinazoline compounds |
| 01/05/1999 | US5855871 Mixing to use |